Annexon (ANNX) Other Accumulated Expenses (2019 - 2026)

Annexon's (ANNX) quarterly Other Accumulated Expenses came in at $11.0 million in Q1 2026, up 4508.37% year-on-year from $239000.0 in Q1 2025, and down 32.37% quarter-over-quarter from $16.3 million in Q4 2025.

Annexon (ANNX) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

Annexon's Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $11.0 million for Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 4508.37% year-over-year to $11.0 million in Q1 2026; TTM through Mar 2026 was $11.0 million, a 4508.37% increase from a year earlier, with the FY2025 full-year figure at $16.3 million, up 11449.65% from the prior year.
  • Other Accumulated Expenses eased to $11.0 million in Q1 2026 per ANNX's latest filing, from $16.3 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $16.3 million in Q4 2025 and bottomed at $79000.0 in Q3 2023.
  • The 5-year median for Other Accumulated Expenses is $164000.0 (2022), against an average of $3.3 million.
  • Across the five-year window, Other Accumulated Expenses sank 94.82% in 2022 and jumped 11449.65% in 2025, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $180000.0 in 2022, then retreated by 21.67% to $141000.0 in 2023, then changed by 0.0% to $141000.0 in 2024, then soared by 11449.65% to $16.3 million in 2025, then sank by 32.37% to $11.0 million in 2026.
  • Per Business Quant, the three latest ANNX Other Accumulated Expenses figures stand at $11.0 million (Q1 2026), $16.3 million (Q4 2025), and $15.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 472.04 Bn 467.25 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.28 Bn 115.03 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn
7 Belite Bio 62.66 Bn 62.66 Bn -
8 Argenx Se 56.16 Bn 50.98 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.56 Bn 34.55 Bn 959.66 Mn
10 Annexon 1.03 Bn 1.03 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 11.01 Mn
Dec 31, 2025 16.29 Mn
Sep 30, 2025 15.76 Mn
Jun 30, 2025 132,000.00
Mar 31, 2025 239,000.00
Dec 31, 2024 141,000.00
Sep 30, 2024 206,000.00
Jun 30, 2024 113,000.00
Mar 31, 2024 4.53 Mn
Dec 31, 2023 141,000.00
Sep 30, 2023 79,000.00
Jun 30, 2023 161,000.00
Mar 31, 2023 7.51 Mn
Dec 31, 2022 180,000.00
Sep 30, 2022 164,000.00
Jun 30, 2022 120,000.00
Mar 31, 2022 84,000.00
Dec 31, 2021 2.40 Mn
Sep 30, 2021 3.17 Mn
Jun 30, 2021 298,000.00